Skip to main content
TipRanks
Go Ultimate75% OFF

Sanofi (SNW) Stock Statistics & Valuation Metrics

35 Followers

Total Valuation

Sanofi has a market cap or net worth of EUR 100.45B. The enterprise value is EUR 108.09B.

Market Cap
EUR 100.45B
Enterprise Value
EUR 108.09B

Share Statistics

Sanofi has 1,207,773,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,207,773,400
Owned by Insiders
―
Owned by Institutions
28.97%

Financial Efficiency

Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.70%.

Return on Equity (ROE)
0.11
Return on Assets (ROA)
0.06
Return on Invested Capital (ROIC)
7.70%
Return on Capital Employed (ROCE)
0.10
Revenue Per Employee
624.16K
Profits Per Employee
104.39K
Employee Count
74,846
Asset Turnover
0.37
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Sanofi is 24.57. Sanofi’s PEG ratio is -0.46.

PE Ratio
24.57
PS Ratio
2.02
PB Ratio
1.41
Price to FCF
6.24
Price to Operating Cash Flow
5.96
PEG Ratio
-0.46

Income Statement

In the last 12 months, Sanofi had revenue of 46.72B and earned 7.81B in profits. Earnings per share was 6.40.

Revenue
46.72B
Gross Profit
33.67B
Operating Income
9.60B
Pretax Income
6.02B
Net Income
7.81B
EBITDA
12.48B
Earnings Per Share (EPS)
6.40

Cash Flow

In the last 12 months, operating cash flow was 17.27B and capital expenditures -793.00M, giving a free cash flow of 16.48B billion.

Operating Cash Flow
17.27B
Free Cash Flow
16.48B
Free Cash Flow per Share
13.73

Dividends & Yields

Sanofi pays an annual dividend of EUR 4.12, resulting in a dividend yield of 4.92%

Dividend Per Share
EUR 4.12
Dividend Yield
4.92%
Payout Ratio
52.09%
Free Cash Flow Yield
15.98%
Earnings Yield
4.05%

Stock Price Statistics

Beta
0.58
52-Week Price Change
-2.10%
50-Day Moving Average
74.60
200-Day Moving Average
75.38
Relative Strength Index (RSI)
76.70
Average Volume (3m)
12.74K

Important Dates

Sanofi upcoming earnings date is Jan 28, 2027, Before Open (Not Confirmed).

Last Earnings Date
Oct 30, 2026
Next Earnings Date
Jan 28, 2027
Ex-Dividend Date
May 05, 2026

Financial Position

Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 28.48%

Current Ratio
1.09
Quick Ratio
1.09
Debt to Market Cap
0.18
Net Debt to EBITDA
1.04
Interest Coverage Ratio
15.33

Taxes

In the past 12 months, Sanofi has paid 1.04B in taxes.

Income Tax
1.04B
Effective Tax Rate
0.17

Enterprise Valuation

Sanofi EV to EBITDA ratio is 7.92, with an EV/FCF ratio of 7.10.

EV to Sales
2.29
EV to EBITDA
7.92
EV to Free Cash Flow
7.10
EV to Operating Cash Flow
6.77

Balance Sheet

Sanofi has EUR 6.35B in cash and marketable securities with EUR 23.58B in debt, giving a net cash position of -EUR 17.23B billion.

Cash & Marketable Securities
EUR 6.35B
Total Debt
EUR 23.58B
Net Cash
-EUR 17.23B
Net Cash Per Share
-EUR 14.26
Tangible Book Value Per Share
EUR 1.05

Margins

Gross margin is 73.44%, with operating margin of 21.55%, and net profit margin of 8.19%.

Gross Margin
73.44%
Operating Margin
21.55%
Pretax Margin
11.59%
Net Profit Margin
8.19%
EBITDA Margin
28.96%
EBIT Margin
13.44%

Analyst Forecast

The average price target for Sanofi is EUR 95.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 95.15
Price Target Upside
13.66% Upside
Analyst Consensus
Moderate Buy
Analyst Count
14
Revenue Growth Forecast
15.30%
EPS Growth Forecast
-35.58%